How has been the historical performance of Remedium Life?

Answer:The historical performance of Remedium Life shows a total operating income of 405.25 Cr for the year ending March 2025, with a total expenditure of 406.34 Cr, resulting in an operating profit (PBDIT) of -1.09 Cr. After accounting for other income of 10.80 Cr, the operating profit stands at 9.71 Cr. The profit before tax is reported at 4.38 Cr, leading to a profit after tax of 2.13 Cr. The earnings per share (EPS) is 0.04, with a profit after tax margin of 0.53%. The company has no long-term borrowings and total liabilities amounting to 1,720.31 Cr, while total assets are equal to the same figure. The cash flow from operating activities is negative at -1,134.00 Cr, but cash flow from financing activities shows a positive inflow of 1,136.00 Cr, resulting in a net cash inflow of 1.00 Cr.

Breakdown:
Remedium Life's financial results for March 2025 indicate a total operating income of 405.25 Cr, with expenditures slightly exceeding income at 406.34 Cr, leading to an operating loss of 1.09 Cr before other income. The inclusion of 10.80 Cr in other income results in a positive operating profit of 9.71 Cr. The company reports a profit before tax of 4.38 Cr, which translates to a profit after tax of 2.13 Cr, reflecting a modest profit margin of 0.53%. On the balance sheet, total liabilities and total assets are both recorded at 1,720.31 Cr, with no long-term borrowings. The cash flow analysis reveals significant challenges, as cash flow from operating activities is heavily negative at -1,134.00 Cr, although financing activities provide a slight offset with a positive inflow of 1,136.00 Cr, culminating in a minimal net cash inflow of 1.00 Cr.